The Patient is the Main Protagonist of His Care Journey

What this Trial Is About

Researchers are evaluating a digital tool designed to help patients with Delta hepatitis (HDV) and their caregivers manage liver disease more effectively. This condition is a severe form of viral hepatitis that rapidly progresses to serious liver damage or cancer, often requiring liver transplantation at a young age. The study is part of the MACROLIVER Project and addresses challenges such as limited screening, late diagnosis, and the need for better patient engagement, especially after the recent approval of a new antiviral drug. The study focuses on the ePro-Diary HDV, a mobile phone application that encourages continuous communication between patients and doctors. This app allows patients to monitor key laboratory results, complete quality of life questionnaires, and track overall health status remotely. The digital tool aims to increase patient involvement in their care and improve adherence to medical visits without replacing standard clinical monitoring. Participants will be followed for three years, during which researchers will measure the proportion of scheduled follow-up visits attended each year. The study will assess changes in patients' quality of life using this active remote approach. Throughout the trial, patient health data and questionnaire responses will be collected via the app to support clinicians and enhance patient care management.

ePro Diary - HDV ( MACROLIVER )